Markets:

Overview

News

Currencies

International

Treasuries

Alcon Inc. Ordinary Shares (NY:ALC)

74.25 +0.73 (+0.99%)

Official Closing Price Updated: 4:10 PM EDT, Aug 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022 ↗

January 18, 2022

Upgrades Canaccord Genuity upgraded the previous rating for Fortuna Silver Mines Inc (NYSE:

Via Benzinga

Analyst Ratings For Alcon ↗

January 07, 2022

Alcon (NYSE:ALC) has observed the following analyst ratings within the last qu...

Via Benzinga

Expert Ratings For Alcon ↗

November 11, 2021

Within the last quarter, Alcon (NYSE:ALC) has observed the following analyst ...

Via Benzinga

Where Alcon Stands With Analysts ↗

October 01, 2021

Analysts have provided the following ratings for Alcon (NYSE:ALC) within the ...

Via Benzinga

Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe

January 12, 2022

From Alcon Inc. Investors

Via Business Wire

Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism

January 11, 2022

From Alcon Inc. Investors

Via Business Wire

Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio

January 10, 2022

From Alcon Inc. Investors

Via Business Wire

Where Alcon Stands With Analysts ↗

September 13, 2021

Within the last quarter, Alcon (NYSE:ALC) has observed the following analyst r...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 ↗

January 07, 2022

Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:

Via Benzinga

Alcon inc (ALC) Q3 2021 Earnings Call Transcript ↗

November 10, 2021

ALC earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Alcon Reports Third Quarter 2021 Results

November 09, 2021

From Alcon Inc. Investors

Via Business Wire

Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021

November 08, 2021

From Alcon Inc. Corporate

Via Business Wire

Alcon Strengthens Surgical Glaucoma Portfolio With $475M Ivantis Deal ↗

November 08, 2021

Alcon AG (NYSE: ALC) has agreed to acquire Ivantis Inc for $475 million. Alcon may be required to make additional contingent payments upon the achievement of...

Via Benzinga

Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio

November 08, 2021

From Alcon Inc. Investors

Via Business Wire

Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs

November 01, 2021

From Alcon Inc. Corporate

Via Business Wire

Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care

October 14, 2021

From Alcon Inc. Corporate

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For October 1, 2021 ↗

October 01, 2021

Upgrades Northland Capital Markets upgraded the previous rating for Five9 Inc (NASDAQ:

Via Benzinga

Alcon Honored with FutureEdge 50 Award

September 27, 2021

From Alcon Inc. Corporate

Via Business Wire

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study ↗

September 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...

Via Benzinga

Closed-End Fund Favorites For Global Investing ↗

September 04, 2021

Calamos Global Total Return Fund is a four-star-rated fund. It seeks total return through a combination of capital appreciation and current income, largely through investment in a globally diversified...

Via Talk Markets

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

August 19, 2021

Needham boosted the price target on NVIDIA Corporation (NASDAQ:

Via Benzinga

Stocks That Hit 52-Week Highs On Monday ↗

August 23, 2021

Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG...

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

August 20, 2021

Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs. Highlights: Microsoft (NASDAQ:MSFT) was the biggest company by market cap to set a new 52-week high...

Via Benzinga

46 Biggest Movers From Yesterday ↗

August 19, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday. SGOCO Group, Ltd. (NASDAQ: SGOC) surged 67...

Via Benzinga

Alcon inc (ALC) Q2 2021 Earnings Call Transcript ↗

August 18, 2021

ALC earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Mid-Afternoon Market Update: Crude Oil Down 1.5%; Tuya Shares Plummet ↗

August 18, 2021

Toward the end of trading Wednesday, the Dow traded down 0.27% to 35,249.25 while the NASDAQ rose 0.06% to 14,664.67. The S&P also fell, dropping 0.21% to 4,438.73. The U.S....

Via Benzinga

Topics Stocks

Mid-Day Market Update: Alcon Rises Following Q2 Results; NexPoint Real Estate Finance Shares Slide ↗

August 18, 2021

Midway through trading Wednesday, the Dow traded down 0.12% to 35,299.82 while the NASDAQ fell 0.01% to 14,654.93. The S&P also fell, dropping 0.10% to 4,443.63. The U.S. has...

Via Benzinga

Topics Stocks

34 Stocks Moving In Wednesday's Mid-Day Session ↗

August 18, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday. Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 58% to $...

Via Benzinga

22 Stocks Moving in Wednesday's Pre-Market Session ↗

August 18, 2021

Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares rose 50.6% to $23.12 in pre-market trading. Virpax Pharmaceuticals shares jumped 265% on Tuesday after the company...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.